Literature DB >> 6310067

Production of collagenase and inhibitor (TIMP) by intracranial tumors and dura in vitro.

A N Halaka, R A Bunning, C C Bird, M Gibson, J J Reynolds.   

Abstract

The production of collagenase and collagenase inhibitor (TIMP) by various intracranial tumors (25 meningiomas, eight gliomas, seven metastases, four pituitary adenomas, and five others) was studied in short-term organ culture. While meningiomas produced negligible amounts of collagenase, two metastatic carcinomas of bronchial and breast origin produced significant amounts of the enzyme. Cultures of dura from an invasive meningioma and of bone invaded by a meningioma also produced collagenase. In varying amounts, TIMP was detected in culture media from most of the tumors studied; invasive tumors tended to produce less TIMP than noninvasive tumors. The results are discussed in relation to current views on tissue degradation and mechanisms of tumor invasion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310067     DOI: 10.3171/jns.1983.59.3.0461

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

Review 1.  The role of tissue inhibitor of metalloproteinase-1 in specific aspects of cancer progression and reproduction.

Authors:  R Khokha; P Waterhouse
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 2.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 3.  Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.

Authors:  H L Fillmore; T E VanMeter; W C Broaddus
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 4.  The role of proteolytic enzymes in cancer invasion and metastasis.

Authors:  M J Duffy
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

Review 5.  Stromelysin in tumor progression and metastasis.

Authors:  S McDonnell; L M Matrisian
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

6.  In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.

Authors:  D H Cresson; W C Beckman; R R Tidwell; J D Geratz; G P Siegal
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

Review 7.  Spinal cord tumours: advances in genetics and their implications for treatment.

Authors:  Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

8.  Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype.

Authors:  Carl Wibom; Lina Mörén; Mads Aarhus; Per Morten Knappskog; Morten Lund-Johansen; Henrik Antti; A Tommy Bergenheim
Journal:  J Neurooncol       Date:  2009-04-07       Impact factor: 4.130

9.  Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo.

Authors:  R Khokha; M J Zimmer; S M Wilson; A F Chambers
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

Review 10.  Role of matrix metalloproteinases in invasion and metastasis: biology, diagnosis and inhibitors.

Authors:  S McDonnell; B Fingleton
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.